Dr. Gregory Miller
Dr. Gregory Miller
Internal Medicine - Cardiology
Grand Rapids, MI
Internal Medicine - Cardiology
In practice for
Grand Rapids , MI 49546
Grand rapids , MI 49503
Blue cross blue shield
BCBS Blue Card PPO
Education and Training
Medical / Graduate School
Wayne State University School of Medicine
Pine rest christian health
Spectrum health united memorial kelsey campus
St marys mercy medical center
Grand River Cardiology
St Mary's Of Michigan Med Ctr
Spectrum Health Reed City Hosp
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro.
Atherosclerosis., Dec;183(2):283-92 (2005)
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
JAMA., Oct;294(14):1799-809 (2005)
The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.
Diabetologia., Oct;49(10):2337-40 (2006)
Increase of plasma fibrinogen levels and variability with age in a sample of middle aged healthy men.
Ann. Hum. Genet., Jan;71(Pt 1):43-53 (2007)
Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects.
Ann. Hum. Genet., Jul;71(Pt 4):453-66 (2007)
The plasma kallikrein-kinin system and risk of cardiovascular disease in men.
J. Thromb. Haemost., Sep;5(9):1896-903 (2007)
Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII).
J. Thromb. Haemost., Feb;6(2):259-67 (2008)
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.
Stat Med., Apr;28(8):1218-37 (2009)
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
Circulation., Jan;111(3):278-87 (2005)
A combination of two common thrombomodulin gene variants (-1208-1209TTdelTT and A455V) influence risk of coronary heart disease: a prospective study in men.
Atherosclerosis., Nov;177(1):97-104 (2004)
The -344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men.
Atherosclerosis., May;174(1):81-6 (2004)
Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.
Ann. Hum. Genet., Mar;66(Pt 2):111-24 (2002)
Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study.
Ann. Hum. Genet., Mar;67(Pt 2):97-106 (2003)
A functional haplotype in the 5' flanking region of the factor VII gene is associated with an increased risk of coronary heart disease.
J. Thromb. Haemost., Oct;1(10):2179-85 (2003)
The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.
Eur. Heart J., Dec;22(24):2243-52 (2001)
Does inflammatory proteolytic activity contribute to the increased factor IX activation peptide in men at high risk of coronary heart disease? A preliminary study.
Thromb. Haemost., Mar;87(3):415-20 (2002)
Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease.
Hypertension., Nov;38(5):1054-61 (2001)
An association between plasma free protein s concentration and risk of coronary heart disease in middle-aged men.
Thromb. Res., Jan;101(2):1-11 (2001)
Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men.
Am. J. Med., Jan;110(1):22-7 (2001)
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study.
Lancet., Jul;358(9276):115-9 (2001)
Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency.
Blood., May;87(10):4187-96 (1996)
Fibrinolytic activity and clotting factors in ischaemic heart disease in women.
BMJ., Jun;312(7046):1581 (1996)
Postprandial activation of coagulant factor VII by long-chain dietary fatty acids.
Thromb. Haemost., Sep;76(3):369-71 (1996)
Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad.
J Epidemiol Community Health., Oct;50(5):497-504 (1996)
Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD).
Thromb. Haemost., Aug;78(2):926-9 (1997)
Risk of coronary heart disease and activation of factor XII in middle-aged men.
Arterioscler. Thromb. Vasc. Biol., Oct;17(10):2103-6 (1997)
An association between arterial pulse pressure and variation in the fibrillin-1 gene.
Heart., Oct;78(4):396-8 (1997)
Dietary fatty acids and blood coagulation.
Prostaglandins Leukot. Essent. Fatty Acids., Oct;57(4-5):389-94 (1997)
Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors.
Arterioscler. Thromb. Vasc. Biol., Dec;17(12):3449-60 (1997)
Effects of diet composition on coagulation pathways.
Am. J. Clin. Nutr., Mar;67(3 Suppl):542S-545S (1998)
Sex differences in the determinants of fibrinolytic activity.
Thromb. Haemost., Mar;79(3):587-90 (1998)
Analysis of the association of a heat shock protein70-1 gene promoter polymorphism with myocardial infarction and coronary risk traits.
Dis. Markers., Feb;13(4):227-35 (1998)
Plant monoterpenes do not raise plasma high-density-lipoprotein concentrations in humans.
Am. J. Clin. Nutr., Nov;68(5):1042-5 (1998)
Postprandial effects of an oleic acid-rich oil compared with butter on clotting factor VII and fibrinolysis in healthy men.
Am. J. Clin. Nutr., Dec;68(6):1202-7 (1998)
Postprandial lipaemia and haemostatic factors.
Atherosclerosis., Dec;141 Suppl 1:S47-51 (1998)
Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism.
Am. J. Clin. Nutr., Feb;69(2):220-5 (1999)
Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity.
Eur. J. Hum. Genet., 7(7):821-7 (1999)
Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease.
Circulation., Dec;102(23):2816-22 (2000)
Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers.
Atherosclerosis., Mar;149(1):75-81 (2000)
C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors.
Atherosclerosis., Mar;149(1):139-50 (2000)
Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
Thromb. Haemost., Mar;83(3):421-6 (2000)
Prothrombin activation is increased among asymptomatic carriers of the prothrombin G20210A and factor V Arg506Gln mutations.
Thromb. Haemost., Sep;84(3):396-400 (2000)
Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men.
Circulation., Oct;102(17):2058-62 (2000)
Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men.
Arterioscler. Thromb. Vasc. Biol., Dec;20(12):2663-9 (2000)
Effects of prior moderate exercise on exogenous and endogenous lipid metabolism and plasma factor VII activity.
Clin. Sci., May;100(5):517-27 (2001)
Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.
Thromb. Haemost., May;75(5):767-71 (1996)
Clotting factor VIII and risk of deep-vein thrombosis.
Lancet., Mar;345(8952):804 (1995)
Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study.
Thromb. Haemost., Jan;71(1):38-48 (1994)
Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration.
Arterioscler. Thromb., Feb;14(2):193-8 (1994)
Factor VII coagulant activity and cholesterol changes in premenopausal women consuming a long-term cholesterol-lowering diet.
Arterioscler. Thromb., Aug;14(8):1284-9 (1994)
Factor VIII, ABO blood group and the incidence of ischaemic heart disease.
Br. J. Haematol., Nov;88(3):601-7 (1994)
The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men.
Thromb. Haemost., Jan;73(1):82-6 (1995)
Lipoproteins and thrombosis: effects of lipid lowering.
Curr. Opin. Lipidol., Feb;6(1):38-42 (1995)
Combined use of aspirin and warfarin in primary prevention of ischemic heart disease in men at high risk.
Am. J. Cardiol., Feb;75(6):23B-26B (1995)
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.
Lancet., Oct;342(8879):1076-9 (1993)
Positive association between self-reported fatty food consumption and factor VII coagulant activity, a risk factor for coronary heart disease, in 4246 middle-aged men.
Thromb. Haemost., Aug;70(2):250-2 (1993)
Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition.
Atherosclerosis., Feb;86(2-3):163-71 (1991)
Dr. Gregory Miller M